PLEIOTROPIC EFFECTS OF STATINS
Main Article Content
Abstract
Statins are among the most widely prescribed medications worldwide and are known for their hypolipidemic effects. However, in recent years more and more data have been accumulated regarding the beneficial effects of statins, beyond lowering the cholesterol level alone. The article reviews and analyzes available publications on the pleiotropic effects of statins.
The overview of Russian and foreign sources was performed based on the analysis of materials from scientific medical journals and databases such, as CyberLeninka, Pub Med, and Google Scholar. The data obtained this way expands the understanding of the pharmacological properties of statins and opens new perspectives for their clinical use. In particular, the mechanisms of their influence on common chronic diseases such, as atherosclerosis, cancer, and dementia are considered. Possible influences of statins on the course of the inflammatory process in the context of chronic diseases are as follows: rheumatoid arthritis, chronic liver inflammation.
In addition in one of the publications, mentioned in this article, there was a study that considered the possibility of higher efficacy of lipophilic statins compared to hydrophilic statins.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Chaulin AM, Duplyakov DV. The role of PCSK9 in the regulation of lipoprotein transport (Review). Problems of biological, medical and pharmaceutical chemistry. 2021; 24(l): 22-30. Russian (Чаулин A.M., Дупляков Д.В. Роль PCSK9 в регуляции транспорта липопротеинов (Обзор) //Вопросы биологической, медицинской и фармацевтической химии. 2021.
Т. 24, № 1. С. 22-30.) doi: 10.29296/25877313-2021-01-04
Chaulin AM, Duplyakov DV. On the role of PCSK9 in the development of atherosclerosis: molecular aspects. Molecular medicine. 2021; 19(2): 8-15. Russian (Чаулин А.М., Дупляков Д.В. О роли PCSK9 в развитии атеросклероза: молекулярные аспекты //Молекулярная медицина. 2021. Т. 19, № 2. С. 8-15.) doi: 10.29296/24999490-2021-02-02
Chaulin AM, Van’kov VA. On the importance of pleiotropic effects of statins in the perioperative period during cardiac surgery. Tendentsii razvitiya nauki i obrazovaniya. 2022; 86(3): 118-121. Russian (Чаулин А.М., Ваньков В.А. О значении плейотропных эффектов статинов в периоперационном периоде при операциях на сердце //Тенденции развития науки и образования. 2022. Т. 86, № 3. С. 118-121.) doi: 10.18411/trnio-06-2022-121
Riesen WF. Pleiotropic Effects of Statins – What Is Their Clinical Significance? Praxis (Bern 1994). 2022; 110(2): 86-88.
doi: 10.1024/1661-8157/a003797
Ahsan F, Oliveri F, Goud HK, Mehkari Z, Mohammed L, Javed M, et al. Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Cureus. 2020; 12(9): e10446. doi: 10.7759/cureus.10446
Zhou XD, Kim SU, Yip TC, Petta S, Nakajima A, Tsochatzis E, et al. Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease. Gut. 2024; 73(11): 1883-1892. doi: 10.1136/gutjnl-2024-333074
Tyuganova EA. Pleiotropic effects of statins and their mechanisms. Nauka i prosveshchenie: aktual’nye voprosy, dostizheniya i innovatsii: Sbornik statey VIII Mezhdunarodnoy nauchno-prakticheskoy konferentsii. Penza, 2022. P. 190-192. Russian (Тюганова Е.А. Плейотропные эффекты статинов и их механизмы //Наука и просвещение: актуальные вопросы, достижения и инновации: Сб. статей VIII Междунар. науч.-практ. конф. Пенза, 2022. С. 190-192)
Aminifar E, Tavakkol Afshari HS, Sathyapalan T, Abbasifard M, Sahebkar A. The pleiotropic effects of statins in rheumatoid arthritis. J Pharm Pharmacol. 2023; 75(7): 910-920. doi: 10.1093/jpp/rgad024
Bubnova MG. Adverse effects of statin therapy: real evidence. CardioSomatika. 2019; 10(1): 51-61. Russian (Бубнова М.Г. Нежелательные эффекты терапии статинами: реальные доказательства //CardioСоматика. 2019. Т. 10, № 1. С. 51-61.) doi: 10.26442/22217185.2019.1.190264
Ahmadi M, Amiri S, Pecic S, Machaj F, Rosik J, Łos MJ, et al. Pleiotropic effects of statins: A focus on cancer. Biochim Biophys Acta Mol Basis Dis. 2020; 1866(12): 165968. doi: 10.1016/j.bbadis.2020.165968
Aronov DM, Bubnova MG. Pleiotropic effects of statins at the present stage of their study (focus on atorvastatin). Part II. Noncardiac pleiotropic effects of statins. CardioSomatika. 2012; 3(4): 46-54. Russian (Аронов Д.М., Бубнова М. Г. Плейотропные эффекты статинов на современном этапе их изучения (фокус на аторвастатин). Часть II. Некардиальные плейотропные эффекты статинов //CardioСоматика. 2012. Т. 3, № 4. С. 46-54)
Climent E, Benaiges D, Pedro-Botet J. Hydrophilic or Lipophilic Statins?. Front Cardiovasc Med. 2021; 8: 687585. doi: 10.3389/fcvm.2021.687585
Aronov DM. Pleiotropic effects of statins at the present stage of their study (focus on atorvastatin). Part III. Mechanisms of the pleiotropy of statins. CardioSomatika. 2013; 4(2): 20-26. Russian (Аронов Д.М. Плейотропные эффекты статинов на современном этапе их изучения: фокус на аторвастатин. Часть III. Механизмы плейотропии статинов //CardioСоматика. 2013. Т. 4, № 2. С. 20-26.) doi: 10.26442/CS44996
Chaulin AM. On the clinical significance of the pleiotropic effects of statins. Tendentsii razvitiya nauki i obrazovaniya. 2022; 86(3): 115-118. Russian (Чаулин А.М. О клиническом значении плейотропных эффектов статинов //Тенденции развития науки и образования. 2022. Т. 86, № 3. С. 115-118.) doi: 10.18411/trnio-06-2022-120
Vell MS, Loomba R, Krishnan A, Wangensteen KJ, Trebicka J, Creasy KT, et al. Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality. JAMA Netw Open. 2023; 6(6): e2320222. doi:
1001/jamanetworkopen.2023.20222
Pomeshkina SA, Barbarash OL, Pomeshkin EV, Bragin-Mal’tsev AI. Relationship between the mechanisms of atherosclerosis and prostate cancer: literature review. CardioSomatika. 2023; 14(1): 49-58. Russian (Помешкина С.А., Барбараш О.Л., Помешкин Е.В., Брагин-Мальцев А.И. Механизмы взаимосвязи атеросклероза и рака предстательной железы: обзор литературы //CardioСоматика. 2023. Т. 14, № 1. С. 49-58.) doi: 10.17816/CS195493
Liu W, Chakraborty B, Safi R, Kazmin D, Chang CY, McDonnell DP. Dysregulated cholesterol homeostasis results in
resistance to ferroptosis increasing tumorigenicity and metastasis in cancer. Nat Commun. 2021; 12(1): 5103. doi: 10.1038/s41467-021-25354-4
Nelson ER, Wardell SE, Jasper JS, Park S, Suchindran S, Howe MK, et al. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Science. 2013; 342(6162): 1094-1098. doi: 10.1126/science.1241908
Dautović E, Rustemović-Čorbić M, Srabović N, Softić A, Smajlović A, Husejnović MŠ, et al. Some pleiotropic effects of statins on hepatocellular carcinoma cells: Comparative study on atorvastatin, rosuvastatin and simvastatin. Adv Med Sci. 2023; 68(2): 258-264. doi: 10.1016/j.advms.2023.07.002
Longo J, Freedland SJ, Penn LZ, Hamilton RJ. Statins and prostate cancer-hype or hope? The biological perspective. Prostate Cancer Prostatic Dis. 2022; 25(4): 650-656. doi: 10.1038/s41391-022-00557-y
Ishikawa T, Irie N, Tashiro J, Osaki T, Warita T, Warita K, Naito M. Comparison of the anticancer effects of various statins on canine oral melanoma cells. Vet Comp Oncol. 2024; 22(1): 156-161. doi: 10.1111/vco.12946
Jiang W, Hu JW, He XR, Jin WL, He XY. Statins: a repurposed drug to fight cancer. J Exp Clin Cancer Res. 2021; 40(1): 241. doi: 10.1186/s13046-021-02041-2
Leonova MV. Statins and cognitive functions: are there associated disorders or protection from dementia? Consilium Medicum. 2019; 21(10): 67-73. Russian (Леонова М. В. Статины и когнитивные функции: имеются ли
ассоциированные расстройства или защита от деменции? //Consilium Medicum. 2019. Т. 21, № 10. С. 67-73.) doi: 10.26442/20751753.2019.10.190435
Goldstein LB, Toth PP, Dearborn-Tomazos JL, Giugliano RP, Hirsh BJ, Peña JM, et al. Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol. 2023; 43(10): e404-e442. doi: 10.1161/ATV.0000000000000164
Samaras K, Makkar SR, Crawford JD, Kochan NA, Slavin MJ, Wen W, et al. Effects of Statins on Memory, Cognition, and Brain Volume in the Elderly. J Am Coll Cardiol. 2019; 74(21): 2554-2568. doi:10.1016/j.jacc.2019.09.041
Sodero AO, Barrantes FJ. Pleiotropic effects of statins on brain cells. Biochim Biophys Acta Biomembr. 2020; 1862(9): 183340. doi: 10.1016/j.bbamem.2020.183340
Petek B, Häbel H, Xu H, Villa-Lopez M, Kalar I, Hoang MT, et al. Statins and cognitive decline in patients with Alzheimer’s and mixed dementia: a longitudinal registry-based cohort study. Alzheimers Res Ther. 2023; 15(1): 220. doi:
1186/s13195-023-01360-0